Skip to main content
. 2021 Sep 23;15(11):2923–2940. doi: 10.1002/1878-0261.13094

Fig. 7.

Fig. 7

CTCs and hTERT cfDNA correlate with the prognosis of patients with NSCLC treated with pembrolizumab. (A) Kaplan–Meier survival plot of PFS based on the combination of cfDNA and CTC levels at baseline. (B) Kaplan–Meier survival plot of OS based on the combination of cfDNA and CTC levels at baseline.